Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Hydroxychloroquine and lopinavir/ritonavir arms discontinued in Solidarity trial

July 6, 2020

EC grants conditional marketing authorization for Veklury as treatment of COVID-19

July 6, 2020

ZyCoV-D vaccine candidate for COVID-19 cleared to enter human trials in India

July 6, 2020

Roche describes new HBV antivirals

July 6, 2020

Results of GRECCO-19 trial evaluating colchicine in hospitalized COVID-19 patients

July 6, 2020

COVAX-19 begins phase I study in Australia

July 3, 2020

IBT-V02: Staphylococcus aureus vaccine that confers protection in mouse and rabbit

July 3, 2020

Phase III trial of Kevzara in COVID-19 does not meet primary and key secondary endpoints

July 3, 2020

Spanish approval granted for COVID-19 study using EnteraGam

July 3, 2020

Janssen synthesizes new cyclopentyl nucleoside analogues

July 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...